Thrombin induces endothelin expression in arterial smooth muscle cells

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 278, Issue 5 47-5, 2000, Pages

  Lepailleur Enouf, Delphine ^a   Valdenaire, Olivier ^a   Philippe, Monique ^a   Jandrot Perrus, Martine ^b   Michel, Jean Baptiste ^a  

^a INSERM   (France)

^b Lab Rech Hemostase Thrombose T   (France)

Author keywords

Half life; Mitogen activated protein kinase kinase; Peroxisome proliferator activated receptors; Protein kinase C; Run on

Indexed keywords

BISINDOLYLMALEIMIDE; CHELERYTHRINE; ENDOTHELIN; FENOFIBRATE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEIN KINASE C; THROMBIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE;

ANIMAL CELL; ARTERY MUSCLE; ARTICLE; CONTROLLED STUDY; GENE INDUCTION; GENETIC TRANSCRIPTION; HALF LIFE TIME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; TRANSCRIPTION REGULATION;

EID: 0034080294     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2000.278.5.h1606     Document Type: Article

References (40)

1. Battle T, Arnal JF, Challah M, and Michel J. Selective isolation of rat aortic wall layers and their cell types in culture. Application to converting enzyme activity measurement. Tissue Cell 26: 943-955, 1994.
2. Bezeaud A, Denninger M, and Guillin M. Interaction of human alpha-thrombin and gamma-thrombin with antithrombin III, protein C and thrombomodulin. Eur J Biochem 153: 491-496, 1985.
3. Clozel M, Breu V, Gray G, Kalina B, Löffler B, Burri K, Cassal J, Hirth G, Müller M, Neidhart W, and Ramuz H. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol Exp Ther 270: 228-235, 1994.
4. Delerive P, Martin-Nizard F, Chinetti G, Trottein F, Fruchard J, Najib J, Duriez P, and Staels B. Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway. Circ Res 85: 394-402, 1999.
5. Devchand P, Keller H, Peters J, Vazquez M, Gonzalez F, and Wahli W. The PPARα-leukotriene B4 pathway to inflammation control. Nature 384: 39-43, 1996.
6. Dorfman D, Wilson D, Bruns G, and Orkin S. Human transcription factor GATA-2. Evidence for regulation of preproendothelin-1 gene expression in endothelial cells. J Biol Chem 267: 1279-1285, 1992.
7. Duijvestijn A, van Goor H, Klatter F, Majoor G, van Bussel E, and van Breda Vriesman P. Antibodies defining rat endothelial cells: RECA-1, a pan-endothelial cell-specific monoclonal antibody. Lab Invest 66: 459-466, 1992.
8. Emori T, Hirata Y, Ohta K, Shichiri M, and Marumo F. Secretory mechanism of immunoreactive endothelin in cultured bovine endothelial cells. Biochem Biophys Res Commun 160: 93-100, 1989.
9. Fenton J. Thrombin functions and antithrombotic intervention. Thromb Haemost 74: 493-498, 1995.
10. Fishel R, Eisenberg S, Shai S, Redden R, Bernstein K, and Berk B. Glucocorticoids induce angiotensin-converting enzyme expression in vascular smooth muscle. Hypertension 25: 343-349, 1995.
11. Forman B, Chen J, and Evans R. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci USA 94: 4312-4317, 1997.
12. Gabbiani G, Schmid E, Winter S, Chaponnier C, de Chastonay C, Vandekerckhove J, Weber K, and Franke W. Vascular smooth muscle cells differ from other smooth muscle cells: predominance of vimentin filaments and a specific alpha-type actin. Proc Natl Acad Sci USA 78: 298-302, 1981.
13. Hahn A, Resink T, Scott-Burden T, Powell J, Dohi Y, and Bühler F. Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function. Cell Regul 1: 649-659, 1990.
14. Horie M, Uchida S, Yanagisawa M, Matsushita Y, Kurokawa K, and Ogata E. Mechanisms of endothelin-1 mRNA and peptide induction by TGF-beta and TPA in MDCK cells. J Cardiovasc Pharmacol 17, Suppl 7: S222-S225, 1991.
15. Hu RM, Levin ER, Pedram A, and Frank HJ. Atrial natriuretic peptide inhibits the production and secretion of endothelin from cultured endothelial cells. Mediation through the C receptor. J Biol Chem 267: 17384-17389, 1992.
16. Inoue A, Yanagisawa M, Takuwa Y, Mitsui Y, Kobayashi M, and Masaki T. The human preproendothelin-1 gene. Complete nucleotide sequence and regulation of expression. J Biol Chem 264: 14954-14959, 1989.
17. Iwanaga Y, Kihara Y, Hasegawa K, Inagaki K, Yoneda T, Kaburagi S, Araki M, and Sasayama S. Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats. Circulation 98: 2065-2073, 1998.
18. Kitazumi K and Tasaka K. The role of c-Jun protein in thrombin-stimulated expression of preproendothelin-1 mRNA in porcine aortic endothelial cells. Biochem Pharmacol 46: 455-464, 1993.
19. Lee M, Bloch K, Clifford J, and Quertermous T. Functional analysis of the endothelin-1 gene promoter. Evidence for an endothelial cell-specific cis-acting sequence. J Biol Chem 265: 10446-10450, 1990.
20. Lee M, Dhadly M, Temizer D, Clifford J, Yoshizumi M, and Quertermous T. Regulation of endothelin-1 gene expression by Fos and Jun. J Biol Chem 266: 19034-19039, 1991.
21. Mak J, Nishikawa M, and Barnes P. Glucocorticosteroids increase beta 2-adrenergic receptor transcription in human lung. Am J Physiol Lung Cell Mol Physiol 268: L41-L46, 1995.
22. Malek A, Greene A, and Izumo S. Regulation of endothelin-1 gene by fluid shear stress is transcriptionally mediated and independent of protein kinase C and cAMP. Proc Natl Acad Sci USA 90: 5999-6003, 1993.
23. Marsden PA and Brenner BM. Transcriptional regulation of the endothelin-1 gene by TNF-α. Am J Physiol Cell Physiol 262: C854-C861, 1992.
24. Marsen T, Simonson M, and Dunn M. Thrombin induces the preproendothelin-1 gene in endothelial cells by a protein tyrosine kinase-linked mechanism. Circ Res 76: 987-995, 1995.
25. Morin C, Asselin C, Boudreau F, and Provencher P. Transcriptional regulation of pre-pro-endothelin-1 gene by glucocorticoids in vascular smooth muscle cells. Biochem Biophys Res Commun 244: 583-587, 1998.
26. Resink T, Hahn A, Scott-Burden T, Powell J, Weber E, and Bühler F. Inducible endothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells. Biochem Biophys Res Commun 168: 1303-1310, 1990.
27. Roux S, Löffler B, Gray G, Sprecher U, Clozel M, and Clozel J. The role of endothelin in experimental cerebral vasospasm. Neurosurgery 37: 78-85, 1995.
28. Schoonjans K, Martin G, Staels B, and Auwerx J. Peroxisome proliferator-activated receptors, orphans with ligands and functions. Curr Opin Lipidol 8: 159-166, 1997.
29. Shimada K, Takahashi M, and Tanzawa K. Cloning and functional expression of endothelin-converting enzyme from rat endothelial cells. J Biol Chem 269: 18275-18278, 1994.
30. Staels B, Koenig W, Habib A, Merval R, Lebret M, Torra I, Delerive P, Fadel A, Chinetti G, Fruchart J, Najib J, Maclouf J, and Tedgui A. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. Nature 393: 790-793, 1998.
31. Stasek J and Garcia J. The role of protein kinase C in alpha-thrombin-mediated endothelial cell activation. Semin Thromb Hemost 18: 117-125, 1992.
32. Tchekneva E, Quertermous T, Christman B, Lawrence M, and Meyrick B. Regional variability in preproEndothelin-1 gene expression in sheep pulmonary artery and lung during the onset of air-induced chronic pulmonary hypertension. Participation of arterial smooth muscle cells. J Clin Invest 101: 1389-1397, 1998.
33. Tharaux P, Chatziantoniou C, Casellas D, Fouassier L, Ardaillou R, and Dussaule J. Vascular endothelin-1 gene expression and synthesis and effect on renal type I collagen synthesis and nephroangiosclerosis during nitric oxide synthase inhibition in rats. Circulation 99: 2185-2191, 1999.
34. Tobias A. Thrombin induces the preproendothelin-1 gene in endothelial cells by a protein tyrosine kinase-linked mechanism. Circ Res 76: 987-995, 1995.
35. Tso J, Sun X, Kao T, Reece K, and Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res 13: 2485-2502, 1985.
36. Vouret-Craviari V, Boquet P, Pouysségur J, and Van Obberghen-Schilling E. Regulation of the actin cytoskeleton by thrombin in human endothelial cells: role of rho proteins in endothelial barrier function. Mol Biol Cell 9: 2639-2653, 1998.
37. Vu-Dac N, Schoonjans K, Kosykh V, Dallongeville J, Fruchart J, Staels B, and Auwerx J. Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor. J Clin Invest 96: 741-750, 1995.
38. Yanagisawa M, Inoue A, Takuwa Y, Mitsui Y, Kobayashi M, and Masaki T. The human preproendothelin-1 gene: possible regulation by endothelial phosphoinositide turnover signaling. J Cardiovasc Pharmacol 13, Suppl 5: S13-S17, 1989.
39. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, and Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.
40. Yu J and Davenport A. Secretion of endothelin-1 and endothelin-3 by human cultured vascular smooth muscle cells. Br J Pharmacol 114: 551-557, 1995.